Tina Green

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken H. Young, Carlo Visco et al. · Journal of Clinical Oncology · 2012 · 683 citations · Full text

Medicine, Hematology, Oncology +14

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov et al. · Blood · 2013 · 679 citations · Full text

Medicine, Cancer Biology, Oncology +15

Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18

Dennis Dias, Jeff Van Doren, Sonela A. Schlottmann et al. · Clinical and Vaccine Immunology · 2005 · 243 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma

Tina Green, Ole Nielsen, Karin de Stricker et al. · The American Journal of Surgical Pathology · 2012 · 147 citations

Medicine, Molecular Biology, Molecular Genetics +17

Optimization and Validation of a Multiplex, Electrochemiluminescence-Based Detection Assay for the Quantitation of Immunoglobulin G Serotype-Specific Antipneumococcal Antibodies in Human Serum

Rocio D. Marchese, Derek Puchalski, Pamela Miller et al. · Clinical and Vaccine Immunology · 2009 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17